BTA
Click for more information
0.00% 57.0¢ biota holdings limited

"penny wise, pound foolish"Management saves PR cost, and the...

  1. miso
    757 Posts.
    clock Created with Sketch.
    23/02/13
    01:28
    Post #: 11457152
    "penny wise, pound foolish"

    Management saves PR cost, and the world still thinks Relenza is a compromised B-grade version of a Tamiflu.

    Mean time, "CSIRO scientist Dr Jenny McKimm-Breschkin*, a researcher in the team that developed the first flu drug Relenza" isn't part of Biota, but two companies worth of useless greedy middle management parasites are.

    What a joke on us poor shareholders.


    *http://www.news-medical.net/news/20130222/New-drug-to-safeguard-against-epidemic-and-pandemic-flu-strains.aspx
    BTA Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS New multi-lode gold shoot discovery boosts development potential—find out who's behind this
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.